estudio cuantitativo tres fase realizado clinica medica neurologio unidad terapia intensivo hospital general universitario fase 1 elaborar protocolo dilucion reenvasado transformacion administracion 294 medicamento via sonda enteral diagrama flujo decision procedimiento operacionales estandar dilucion reenvasado transformacion forma farmaceutico oral administracion medicamento via sonda enteral fase 2 investigar retrospectivamente error 872 medicamento prescrito via sonda enteral 293 prescripcion paciente internado marzo junio continuacion capacitacion equipo directriz establecido fase 3 investigar prospectivamente error intervencion farmaceutico 945 medicamento prescrito via sonda enteral 292 prescripcion paciente internado agosto septiembre dato ser colectar formulario estructurado compilado programa microsoft office excel r calcular frecuencia foram observado 786 erro 63 9 502 na fase 2 36 1 284 na fase 3 na fase 3 verificou reducao na frequencia prescricao medicamento via sonda enterai contraindicado sem informaco disponiveis to analyze the impact of guidelines regarding errors in medications prescribed for administration through enteral tubes diretrizes intervenco farmaceutica foram determinante na prevencao dos erro medicamento via sonda enterai directriz intervencion farmaceutico ser determinante prevencion error medicamento via sonda enteral analizar impacto directriz error medicamento prescrito administracion via sonda enteral estudo quantitativo em tres fase realizado em clinica medico neurologia unidade terapia intensivo hospital geral universitario na fase 1 elaborou protocolo diluicao unitarizacao transformacao administracao 294 medicamento via sonda enterais fluxograma decisorio procedimento operacionais padrao diluicao unitarizacao forma farmaceutica orais administracao medicamento via sonda enterai na fase 2 investigou retrospectivamente erro em 872 medicamento prescrito vio sonda enterai em 293 prescrico paciente internado marco junho seguiu capacitacao dos equip diretrizes estabelecida na fase 3 investigou prospectivamente erro intervenco farmaceutica em 945 medicamento prescrito vio sonda enterai em 292 prescrico paciente internado agosto setembro dado coletado em formulario estruturado foram compilado programa microsoft office excel r calculado frequencia 786 errors were observed 63 9 502 in phase 2 and 36 1 284 in phase 3 in phase 3 reduction was ascertained in the frequency of prescription of medications delivered via enteral tubes medications which were contraindicated and tho for which information was not available guidelin and pharmaceutical interventions were determined in the prevention of errors involving medications delivered through enteral tubes analisar impacto diretrizes erro em medicamento prescrito administracao via sonda enterai observar 786 error 63 9 502 fase 2 36 1 284 fase 3 fase 3 verificar reduccion frecuencia prescripcion medicamento via sonda enteral contraindicado informacion disponible quantitative study in three phas undertaken in internal medicine neurology and an intensivir care unit in general teaching hospital in phase 1 the following was undertaken protocol for dilution and unit dose repackaging and administration for 294 medications via enteral tubes decision flowchart operational standard procedur for dilution and unit dose repackaging of oral pharmaceutical forms and for administration of medications through enteral tubes in phase 2 errors in 872 medications prescribed through enteral tubes in 293 prescriptions for patients receiving inpatient treatment between march and june were investigated this was followed by training of the teams in relation to the guidelines established in phase 3 pharmaceutical errors and interventions in 945 medications prescribed through enteral tubes in 292 prescriptions of patients receiving inpatient treatment between august and september were investigated prospectively the datar collected in structured questionnaire were compiled in the microsoft office excel r program and frequencies were calculated